Bernard Courtieu Ph.D.
Chairman and Chief Executive Officer
Bernard Courtieu joined IntegraGen as CEO in September 2007. Prior to joining IntegraGen, Mr. Courtieu achieved significant success as Practice Leader and later as Vice President within Gemini Consulting's Life Sciences Division in France. His tenure with Gemini Consulting and Cap Gemini Ernst & Young yielded hands-on experience in improving the operational performance of pharmaceutical companies in the fields of research and development, industrial operations, supply, sales & marketing and information systems. Previous to this, Mr. Courtieu held the position of Country Manager, France, at Ariba (2004), the world leader in Spend management. In this role, he assisted companies in analyzing and managing their corporate spending in order to achieve increased business process efficiency. Mr. Courtieu holds a MBA from the “Instituto de las Estudios Superiores de la Empresa” (IESE) in Barcelona, Spain. He received his doctorate in Veterinary Medicine from the Ecole Vétérinaire d'Alfort and University Paris XII, France.
Laurence Riot Lamotte
Chief Financial Officer
Laurence Riot Lamotte joined IntegraGen in October 2011 as Chief Financial Officer. She is former CFO of Aureus Science and LBMA. Her previous positions at Deloitte in the Audit Department, and at Thomson, brought her wide operational and international experience, leading to expertise in Strategic Financial spheres. She has also managed several projects for the Deutshe Telekom French subsidiary. Ms. Lamotte has a degree from CESEM management school (RMS Group) and holds a German “Diplombetriebswirt”. She also has a Master degree from Paris-Dauphine University, in the field of “Telecoms and new medias”.
Vice President of R&D and Medical Affairs
François Liebaert joined IntegraGen in 2011 as Vice President of R&D and Medical Affairs. Before joining IntegraGen, he served as Chief Operating Officer and Vice President Business Develpoment & Finance at BioSystems International. Prior to that, Mr. Liebaert held various positions in Medical and Clinical Development and Marketing and Business Development. He has also held management positions at Schering AG and Abbott Laboratories, where he was Marketing Director for the French Hospital Product Division. Mr. Liebaert holds a Medical Degree (1985) from the Medical School of Lille (France) with a specialization in Anaesthesiology and also has an Executive MBA from the HEC business school group.
Sales and Marketing Director, Services and Arrays
Emmanuel Martin joined IntegraGen as Director of Sales & Marketing for the Services Business Unit in 2006. Mr. Martin is responsible for the development of IntegraGen’s business efforts in the field of high quality SNP Genotyping Services and IntegraChips™ sales (high density BAC arrays) direct at the research community. He previously worked for eight years as Senior Sales Specialist in SNP genotyping and gene expression, and then as Business Developer and Research Field Engineer in real Time PCR at Applied Biosystems, Applera, France. Mr. Martin also has over 4 years of research experience in molecular biology. He is a graduate Pharmacist and obtained a French “DEA de Bases Fondamentales de l'Oncogénèse” (Master Degree of applied studies on oncogenesis) from the University of Paris V, France.
Francis Rousseau Ph.D.
Director of Genomics
Francis Rousseau joined Integragen in 2002. As Head of Laboratories, Mr. Rousseau manages the implementation of high-throughput platforms and is in charge of genotyping programs and service projects including SNPlex® and Ilumina®. Mr. Rousseau has worked with both small entrepreneurial biotech companies and large pharmaceutical firms. From 2000 to 2002 Mr. Rousseau held the position of Director of Genotyping at GenOdyssee, where he set up a new ISO 9000 high-throughput SNP genotyping facility platform. Prior to this, he managed a Lab team dedicated to the genomic programs at Aventis Pharma. As a Researcher, Mr. Rousseau developed genotyping platforms and managed projects about the genetics of complex traits such as schizophrenia, Bi-Polar and Parkinson's diseases. Mr. Rousseau received his Ph.D. in Human Genetics from the “Pierre and Marie Curie” University, where his research focused on the localization and identification of a gene involved in dysmorphic dwarfism (achondroplasia, hypochondroplasia and thanatophoric dwarfism) at U393 INSERM Institute under the direction of Prof. Arnold Munnich.
General Manager, IntegraGen, Inc.
Larry Yost, R.P.h. is General Manger for IntegraGen Inc. and is responsible for the company’s activities in the United States. Mr. Yost has over 25 years of domestic and international medical technology experience with both small venture-capital startup companies and large multi-national organizations. Mr. Yost is a results-oriented leader with a proven track record of bringing change technology to the market and interacting with key opinion leaders to drive the adoption of innovative technology. Prior to joining IntegraGen, Mr. Yost was the Vice-President of Sales and Marketing for Expanding Orthopedics, a venture-capital backed company developing novel medical implant technology for spinal fusion and orthopaedic trauma. Mr. Yost has also previously led marketing teams at Salient Surgical Technologies and at Vasca Inc. Larry began his career as a sales representative and then as a Medical Sciences Liaison at the Upjohn Company (subsequently acquired by Pfizer), followed by a global marketing role with Baxter Healthcare. Larry has a Bachelor’s of Science Degree from the Purdue University School of Pharmacy.